pharmaceutical industry

Valeant scandal result of focus on short term

A National Observer article suggests that a root cause of the Valeant scandal was a focus on what was happening to the price of shares in the short term. According to the article, the decision to cut R&D and borrow heavily to finance takeovers led to a revenue increase, which in turn caused a significant increase in share prices.